Sunresin

Sunresin supplies advanced ion exchange and adsorbent resins as well as chromatography media and solid-phase supports for pharmaceutical manufacturing, bioprocessing, peptide/oligonucleotide synthesis, enzyme catalysis, and industrial separations. Their products are widely adopted by global pharma/biotech manufacturers for purification of antibiotics, peptides/proteins/mAbs/vitamins/APIs/excipients. The company does not conduct clinical trials or develop drugs directly but enables efficient production of high-purity pharmaceuticals through its materials. In addition to healthcare/life science applications, they have significant business in water treatment and new energy sectors. Financially robust with $350M+ revenue in 2023.